Méthode pour mesurer quantitativement la resistence multiple aux médicaments anti-tumeurs

Jose Remacle; Thomas Efferth; Jean-Pierre Gillet

Méthode pour mesurer quantitativement la resistence multiple aux médicaments anti-tumeurs

Jose Remacle (Inventeur), Thomas Efferth (Inventeur), Jean-Pierre Gillet (Inventeur)

Résultats de recherche: Brevet

Résumé

The invention relates to a method for determining, whether a cell of interest is resistant to an active substance to which it is exposed, e.g. during cancer chemotherapy. The method comprises the quantitative analysis of the expression of at least 5 ABC transporter genes within a sample, treated in the same manner using a DNA micro-array.

Titre traduit de la contribution	A method for quantitative determination of multi-drug resistance in tumours
langue originale	Français
Numéro de brevet	EP1550731
CIB	C12Q 1/ 68 A I
Date de priorité	30/12/03
Etat de la publication	Publié - 6 juil. 2005

SDG des Nations Unies

Ce résultat contribue à ou aux Objectifs de développement durable suivants

Contient cette citation

@misc{18eae3adce33407c8d83b47557123f2e,

title = "M{\'e}thode pour mesurer quantitativement la resistence multiple aux m{\'e}dicaments anti-tumeurs",

abstract = "The invention relates to a method for determining, whether a cell of interest is resistant to an active substance to which it is exposed, e.g. during cancer chemotherapy. The method comprises the quantitative analysis of the expression of at least 5 ABC transporter genes within a sample, treated in the same manner using a DNA micro-array.",

author = "Jose Remacle and Thomas Efferth and Jean-Pierre Gillet",

year = "2005",

month = jul,

day = "6",

language = "Fran{\c c}ais",

type = "Patent",

note = "EP1550731; C12Q 1/ 68 A I",

}

TY - PAT

T1 - Méthode pour mesurer quantitativement la resistence multiple aux médicaments anti-tumeurs

AU - Remacle, Jose

AU - Efferth, Thomas

AU - Gillet, Jean-Pierre

PY - 2005/7/6

Y1 - 2005/7/6

N2 - The invention relates to a method for determining, whether a cell of interest is resistant to an active substance to which it is exposed, e.g. during cancer chemotherapy. The method comprises the quantitative analysis of the expression of at least 5 ABC transporter genes within a sample, treated in the same manner using a DNA micro-array.

AB - The invention relates to a method for determining, whether a cell of interest is resistant to an active substance to which it is exposed, e.g. during cancer chemotherapy. The method comprises the quantitative analysis of the expression of at least 5 ABC transporter genes within a sample, treated in the same manner using a DNA micro-array.

M3 - Brevet

M1 - EP1550731

ER -

Méthode pour mesurer quantitativement la resistence multiple aux médicaments anti-tumeurs

Résumé

SDG des Nations Unies

Empreinte digitale

Contient cette citation